![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » INDIAN GENERIC DRUG MAKER RANBAXY PLANNING TO BUY RUSSIAN FIRM
INDIAN GENERIC DRUG MAKER RANBAXY PLANNING TO BUY RUSSIAN FIRM
August 21, 2006
Indian pharmaceutical firm Ranbaxy Laboratories Ltd. is said to be close to acquiring Russian generic drug maker Akrikhin for nearly $100 million, according to speculative media reports. The company, India's top drug maker by sales, hopes to get an enhanced foothold in the Russian market, where its sales accounted for more than $30 million in 2005. Earth Times (http://www.earthtimes.org/articles/show/8247.html)
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct